Does PIRTOBRUTINIB Cause Splenomegaly? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Splenomegaly have been filed in association with PIRTOBRUTINIB (JAYPIRCA). This represents 2.8% of all adverse event reports for PIRTOBRUTINIB.
12
Reports of Splenomegaly with PIRTOBRUTINIB
2.8%
of all PIRTOBRUTINIB reports
12
Deaths
12
Hospitalizations
How Dangerous Is Splenomegaly From PIRTOBRUTINIB?
Of the 12 reports, 12 (100.0%) resulted in death, 12 (100.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Splenomegaly Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIRTOBRUTINIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does PIRTOBRUTINIB Cause?
Death (65)
Malignant neoplasm progression (43)
Disease progression (41)
Pneumonia (41)
Anaemia (27)
Chronic lymphocytic leukaemia (25)
Pancytopenia (22)
Off label use (21)
Drug ineffective (20)
White blood cell count increased (19)
What Other Drugs Cause Splenomegaly?
RUXOLITINIB (1,995)
RITUXIMAB (326)
PREDNISONE (299)
IBRUTINIB (279)
CYCLOPHOSPHAMIDE (254)
METHOTREXATE (253)
OXALIPLATIN (253)
ADALIMUMAB (245)
TACROLIMUS (218)
IMATINIB (216)
Which PIRTOBRUTINIB Alternatives Have Lower Splenomegaly Risk?
PIRTOBRUTINIB vs PIT VIPER IMMUNE GLOBULIN ANTIVENIN
PIRTOBRUTINIB vs PITAVASTATIN
PIRTOBRUTINIB vs PITOLISANT
PIRTOBRUTINIB vs PIXANTRONE
PIRTOBRUTINIB vs PIZOTYLINE